Sickle cell disease (SCD), affecting ∼100,000 Americans, is the most common inherited blood disorder in the US and is associated with significant morbidity and cost. This study aims to determine the variation in SCD hospitalization outcomes across 2 HCUP datasets.
No takes yet. Share an insight, caveat, or question.
Ambegaonkar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: